SBI is proud to announce the newest addition to their growing family of COVID-19 research tools, pPACK-SPIKE B.1.351 RBD Mutations Lentivector Packaging Mix. This pPACK-SPIKE version enables production of lentivirus pseudotyped with the SARS-CoV-2 spike protein containing receptor binding domain mutations K417N, E484K, N501Y from emerging lineage B.1.351, also known as 501Y.V2 or the "South African" variant.
Like the previously released pPACK-SPIKE lentivirus packaging mixes, pPACK-SPIKE B.1.351 RBD Mutations gives you the ability to efficiently study this spike protein variant under BSL-2 conditions, such as for neutralization assays and therapeutic discovery.
|pPACK-SPIKE B.1.351 RBD Mutations, SARS-CoV-2 "S" Pseudotype - B.1.351 (S. African) Variant - RBD Mutations - Lentivector Packaging Mix (10 rxn)||CVD19-580A-1|
|pPACK-SPIKE B.1.351 RBD Mutations, SARS-CoV-2 "S" Pseudotype - B.1.351 (S. African) Variant - RBD Mutations - Lentivector Packaging Mix (25 rxn)||CVD19-585A-1|
|pPACK-SPIKE B.1.351 RBD Mutations Combo Kit, includes Cat# CVD19-580A-1, plus PureFection Transfection Reagent (Cat# LV750A-1) and PEG-it Virus Concentration solution (Cat# LV810A-1)||CVD19-589A-KIT|